Bookmark

Prophylactic Role of Immunomodulators in Treatment of Systemic Candidiasis in Leukopenic Mice

Khan, M. Alam; Firoz, Ahmad; Jabeen, R.; Mohammad, O.
Journal of Drug Targeting , Volume 12 (7) Informa HealthcareAug 1, 2004

Preview Only

Prophylactic Role of Immunomodulators in Treatment of Systemic Candidiasis in Leukopenic Mice

Abstract

In the present study, we have evaluated prophylactic role of various immunomodulators viz. lipopolysachharide, protein A and tuftsin to impart protection against experimental candidiasis in leukopenic mice. Both free as well as liposomised form of nystatin was not effective enough in offering complete cure against less susceptible isolate of Candida albicans (JNMCR) infection in immunodebilitant mice. Interestingly, the pretreatment of leukopenic mice with immunomodulators before challenging them with C. albicans increased therapeutic efficacy of the nystatin against systemic candidiasis. Efficacy of the treatment was evaluated on the basis of survival of the animals as well as fungal load in systemic circulation and various organs viz. liver, kidney, spleen and lungs of the treated animals.
Loading next page...
1 Page

Preview Only. This article cannot be rented because we do not currently have permission from the publisher.

 
/lp/informa-healthcare/prophylactic-role-of-immunomodulators-in-treatment-of-systemic-wwy6YbYVzs
Title
Prophylactic Role of Immunomodulators in Treatment of Systemic Candidiasis in Leukopenic Mice
Author(s)
Khan, M. Alam; Firoz, Ahmad; Jabeen, R.; Mohammad, O.
Journal
Journal of Drug Targeting , Volume 12 (7) Informa Healthcare – Aug 1, 2004
Publisher
Informa UK Ltd
Copyright
© 2004 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted
Subject
Research Article
ISSN
1061-186X
eISSN
1029-2330
D.O.I.
10.1080/10611860412331285215
Publisher site
Get PDF